ARCHIVES

Study Finds 4-20% Of Those With HTLV-3 Develop AIDs Within 32 Months Or Less

This article is from The Cancer Letter archive.

Vol. 11 No. 31 | August 2, 1985

Download PDF Visit The Full Archive

Related Articles

Bypass Budget Going to White House Next Month Will Seek Optimal Funding for Cancer Program

August 22, 1980

Guest Editorial: Omics Checklist Done, Now Create Business Model For Tests

February 7, 2013

AZT Trial Unblended, Controls Get Drugs; Gallo, Essex Win Lasker With Montagnier

September 26, 1986

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

December 14, 2001

(8-page issue)

November 2, 2002

Intramural Pis To Control Own Budgets, Have Greater Autonomy, Klausner Says

December 15, 1995